Board of Pharmacy
Helpful Links
- U.S. FDA Purple Book Database of Licensed Biological Products
- Buprenorphine Treatment Guidelines
- Abuse-Deterrent Opioid Analgesics
- COVID-19 Information
- DEA Diversion Control Division
- DEA Interim Policy: Multiple Prescriptions
- DEA Pharmacist Manual
- Electronic Code of Federal Regulations
- Frequently Asked CSMD Questions (FAQ)
- HIPAA and the Board of Pharmacy
- Information Regarding Approved Biosimilars
- Mandatory Practitioner Profile
- Meth-Free Tennessee Act of 2005
- New Gabapentin Law Effective July 1, 2018
- Patients and health care providers can learn about postmarket drug safety information
- Prescription Writing Format for Nurse Practitioners
- U.S. Food & Drug Administration
- Volunteer for Mass Emergency Clinics
Drug Disposal Locations
- Drug Disposal – safe.pharmacy
- Controlled Substance Public Disposal Location - usdoj/gov
- To subscribe to the Tennessee Board of Pharmacy Newsletter Alert e-mail list, go the link below for past letters and to add yourself to the mailing list: https://nabp.pharmacy/bop_members/tennessee/